Aquestive Therapeutics Inc (AQST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2018 | 12-2017 | 12-2006 | |
Sales | 67,430 | 66,918 | 0 |
Cost of Goods | 20,988 | 19,820 | N/A |
Gross Profit | 46,442 | 47,098 | N/A |
Operating Expenses | 96,369 | 48,031 | 0 |
Operating Income | -48,934 | -113 | N/A |
Interest Expense | 7,711 | 7,707 | 0 |
Other Income | -4,731 | -1,123 | 0 |
Pre-tax Income | -61,376 | -8,943 | 0 |
Net Income Continuous | -61,376 | -8,943 | N/A |
Net Income | $-61,376 | $-8,943 | $N/A |
EPS Basic Total Ops | -2.96 | N/A | N/A |
EPS Basic Continuous Ops | -2.96 | N/A | N/A |
EPS Diluted Total Ops | -2.96 | N/A | N/A |
EPS Diluted Continuous Ops | -2.96 | N/A | N/A |
EPS Diluted Before Non-Recurring Items | -2.80 | N/A | N/A |
EBITDA(a) | $-44,007 | $5,548 | $N/A |